Nexalin Technology (NXL) Gross Margin Growth (1y) (2022 - 2026)
Nexalin Technology (NXL) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 128.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 448.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 305.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -6.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 391.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 153.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -4,158.00 |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 69.00 |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | 551.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 551.00 |
| Mar 31, 2026 | 2,090.00 |
| Dec 31, 2025 | 1,535.00 |
| Sep 30, 2025 | 1,348.00 |
| Jun 30, 2025 | -535.00 |
| Mar 31, 2025 | -2,142.00 |
| Dec 31, 2024 | -211.00 |
| Sep 30, 2024 | -1,875.00 |
| Jun 30, 2024 | -62.00 |
| Mar 31, 2024 | 1,163.00 |
| Dec 31, 2023 | -760.00 |
| Sep 30, 2023 | 1,787.00 |
| Jun 30, 2023 | 332.00 |
| Mar 31, 2023 | -903.00 |
| Dec 31, 2022 | -2,206.00 |
| Sep 30, 2022 | -1,772.00 |